COMMUNIQUÉS West-GlobeNewswire

AVROBIO, Inc. to Present at Upcoming Investor Conferences
28/08/2018
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene therapies [...]
OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
28/08/2018
MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States [...]
Progressive Care Inc. Earns International Media Coverage in Top Industry Outlets on Its Healthcare Technology Expertise
28/08/2018
MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that Chief Executive Officer S. Parikh Mars has earned [...]
Immunomedics Announces Participation in Upcoming Healthcare Conferences
28/08/2018
MORRIS PLAINS, N.J., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference
28/08/2018
Company to Webcast Presentation on Wednesday, September 5 at 10:50 am ET AUSTIN, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs [...]
Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference
28/08/2018
Highlights include eleven presentations covering SPR994’s pharmacokinetics and pharmacodynamics, SPR206’s broad spectrum of activity and favorable toxicology, and urinary tract infection epidemiology CAMBRIDGE, Mass., [...]
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018
28/08/2018
FRAMINGHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Theratechnologies Files Marketing Authorization Application for Trogarzo™ in Europe
28/08/2018
MONTREAL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the application for marketing authorization of Trogarzo™ (ibalizumab) was filed with the [...]
Theratechnologies soumet la demande d’autorisation de mise en marché de Trogarzo(MC) en Europe
28/08/2018
MONTRÉAL, 28 août 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que la demande d’autorisation de mise en marché de Trogarzo MC (ibalizumab) a été soumise auprès de [...]
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
28/08/2018
DUBLIN, Ireland and TREVOSE, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Strongbridge Biopharma plc Announces New Employment Inducement Awards
28/08/2018
DUBLIN, Ireland and TREVOSE, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab
28/08/2018
Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at 48 Months CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) [...]
Assembly Biosciences to Present at Upcoming Investor Conferences
28/08/2018
SAN FRANCISCO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), today announced that the company will be participating in the following upcoming investor conferences in September: Baird [...]
Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Management of Acne Vulgaris
28/08/2018
Lead Researcher Mark Steven Nestor, M.D., Ph.D. Presented the Results of the Study at the Practical Symposium Dermatology Conference August 9-12, 2018 PETALUMA, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sonoma [...]
Protech Home Medical Releases Third Quarter Financial Results
28/08/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
Kymriah® (tisagenlecleucel, formerly CTL019) receives European Commission Approval
28/08/2018
Kymriah ® (tisagenlecleucel, formerly CTL019) receives European Commission Approval London, UK – 28 August 2018: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group [...]
AxoGen, Inc. to Present at the Morgan Stanley Global Healthcare Conference
28/08/2018
ALACHUA, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, chief [...]
Aleafia Posts Record Revenue in Q2 with 160,000 sq ft Niagara Greenhouse to be Fully Operational in Late 2018
28/08/2018
Annual growing capacity to reach 38,000 kg in early 2019 TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“ Aleafia “) or (the “ Company “), one of [...]

Pages